Diagnosis to treatment interval (DTI) is associated with adverse outcome in newly diagnosed patients with mantle cell lymphoma, a MER/LEO and Alliance collaboration
- Citation:
- Blood vol 132 (suppl 1) 2878
- Meeting Instance:
- ASH 2018
- Year:
- 2018
- Type:
- Abstract
- Sub type:
- Poster Discussion
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- Alliance-data-source,-external-user
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 3479
- Pharmas:
- Grants:
- U10CA180821, U10CA180882
- Corr. Author:
- Authors:
- Matthew J. Maurer Amy S. Ruppert Brian K. Link Lawrence D. Kaplan David Inwards Andrew Feldman Eric D. Hsi Adam Pettinger Jonathon Cohen Peter Martin Brad Kahl Nancy Bartlett James R. Cerhan John P. Leonard Thomas M. Habermann
- Networks:
- CA136, IA018, LAPS-MN026, LAPS-MO011, NY018
- Study
- Alliance-A151814
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- N/A
- Keywords: